{"name":"Cellf Bio LLC","slug":"cellf-bio-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQeEpLeGZFSEdaWE9INEc2WWlTa3VFUW1JUnd5Q3loY2pIeW1ROTdEZzA3cHVXM3BjMUhVdC1MN1FjTmJDaVI5SWx5LUI5SUM4d3FIQWJOZW1ldmtMc2dXLVEtbTVPaGY3bU9nM1hKTl9SOFlFWE1wSFRuWjd5ZkJ1QkNRb05YM3ZPX3NwOUJWMS05MGpnZWJvNXZPOVFRUU5Zb0tQUXM4MA?oc=5","date":"2026-04-01","type":"regulatory","source":"Fierce Pharma","summary":"FDA extends review of Orca Bio’s novel cell therapy for blood cancers - Fierce Pharma","headline":"FDA extends review of Orca Bio’s novel cell therapy for blood cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAzMndaeFE4SDJ4X0ZYTlVxLWYtbTlrelJwYVNCS3BwVWRMVHZmVXRmejRfUHlLUU5Pa2JXa05kcmh4TzM4SFpSNE43cGpOREZpbVBoalpQSF9HUVRaN0VpUDRCdDF3UUxqaXhYTlNB0gFzQVVfeXFMT0hhd1p2dmV2M3NjZzNETXVHR25DeVZhMmJzMGVmeXJnRHNsUWRvWE9JUWxxbUswcW5HX090M0w5Y0pPbTIxcEhFVU1mWU5ieU5jSktLcTk5NUp3Y2NDWUpEUC1kWVRDaHoxVXJiOEVmMHBEQQ?oc=5","date":"2026-02-02","type":"pipeline","source":"BioInformant","summary":"Top iPSC Providers Transforming Preclinical Safety for Big Pharma - BioInformant","headline":"Top iPSC Providers Transforming Preclinical Safety for Big Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPSzhIMDVxbHRlaWNEdDZYanBOZi1FRDZDblZDRW1FSE44cW82MXJlNFhmR2RyQ1NwN1RmMnROd0p1ZGFpckd5a0Z1a0pkWTExT2lJNUFNSlp6VU5PazZ6dkwtQ2JiNFJYMm1VclMzYVcwSC1JQldSNGIta1R3SDlGRWVuOUZfTnFDU0lOYlNibW9NcjlJMmhLcHYzRlMwbEJKQVh3?oc=5","date":"2026-01-09","type":"pipeline","source":"Fierce Pharma","summary":"Orca rides $250M funding wave toward cancer cell therapy launch - Fierce Pharma","headline":"Orca rides $250M funding wave toward cancer cell therapy launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQWFhFT2RROUMwS0doQ2tWSmJjN1Rjb2ZHTG1wSkpfTUx5SlJqeDBfRjE4TmdkVEJfM1pYUmo0c2hkbmlkVWRMUkQ3M3ZjblBBb0RpN0hDOXdJaUxOUG5SLWdvbGtsVkJhUjFHRmo0SHhFeFItUU5TclFOVHJ3N2lyUm5oMnF1a25qX0QzdzhmMFNxMVY3b1hlbUJlTFlzUExCbzZENnllUHROTUFyY2RZWlRB?oc=5","date":"2025-08-25","type":"pipeline","source":"Fierce Biotech","summary":"Cell therapy biotech Appia shuts down as funding runs dry - Fierce Biotech","headline":"Cell therapy biotech Appia shuts down as funding runs dry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT3IyUDBxWEczM2xYTGV4bmJVRE5VOW1NZ01DZklxUUdDUHV5LTZIUUhnRVFCaWM0ZEhINER6MWEyX19vQkl6b0VMRTR1RGZ2V1NiRHYxdVcxdkRiS3BFWnNSRTZxY0J6UEJ2ZkRIM1ROTm51SVEtSzNldHMzamxER0FYV080aGJlaHZkN3NDUktLRTVpbzNiUWxYdUl3WFU4Z2s5dExTVkpUaFBNeGZKc1lndVhmeHA2SEpkQ2NYQjJFdw?oc=5","date":"2025-07-28","type":"pipeline","source":"Fierce Pharma","summary":"From cell and gene to biomanufacturing, North Carolina harnesses local talent to drive state's life sciences surge - Fierce Pharma","headline":"From cell and gene to biomanufacturing, North Carolina harnesses local talent to drive state's life sciences surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOcEVJeTJzV09OYjZYZ081YWVBODI5c0NPU09CaEJSdVRtcktlaENyQ3puaUZvby0xQzlqc2QyMUJ0U0dBMlhpa3NtcklBNlNHcGUxUEJCb0ZyREZBa2QwYXFxRElVSW1SUzQ0MWpMVm1ucGdpVEtCaVAzdC1iQVo4YkhMSWh2MHpxa0hZSGgtVjhzUQ?oc=5","date":"2025-05-15","type":"pipeline","source":"Contract Pharma","summary":"Kincell Bio Completes $22M Investment Round - Contract Pharma","headline":"Kincell Bio Completes $22M Investment Round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOVkVVUmlvczJycWlSN0RCRWwwOEN4dk9iX0JvWEI0dHBSTGRSVHZsNnRxaG9HM01WRGdjemZjWW5ydjBXWHNoNUdnckNUbTE3MXd4UndtbWV5VlFPZnkxQ2g4NWpUb0dxRXZldGdiSEV6Z25lNUlmMjF4MF9lcTAybVVyU1RITWZEUlRXN3M5TXgtNXNHWjVUVElqdHpOVW8xb3d4TGg0MkNiY1k?oc=5","date":"2025-05-08","type":"trial","source":"Fierce Biotech","summary":"Vor Bio to wind down, halting cell therapy trials and shedding most staff - Fierce Biotech","headline":"Vor Bio to wind down, halting cell therapy trials and shedding most staff","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNc1VMVjVmQlNTbUdndnF3XzlkS3FaVGJlclFVYkw5WDN1bnBsMnhEcEt3d1ozN2QxbDNSQTBtV0FxNWpnODhoVkxfS2E4S2tsOHZqWGlGM3VXcUVsSG94NzBGc1EwMmdxcVVKX0RpWlMwWnZPeEx0UmJCQmdjNVYyWXVzUFU4MUlqaC1DbkRRTlBicXJlUmI2d0kzQ1pTbnJyV0tOaVNweVEzZTlFQ3p0REZNSVpmTXB6M0NGTkxHMmhLdGl4RnZ1WF9FS0NCdXhRbktkQ3lhOGRsUklGTVpR?oc=5","date":"2025-03-11","type":"deal","source":"Reuters","summary":"Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million - Reuters","headline":"Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPaVVxUUJHMF9kaTRQWmNEbUxZWWZpY252b0dia3RtRU94OHdQZERrZWw3OVNhWUpKNmpmdlZSQS1jaTBJbU9LR29rN0doNVdZU3ZXNFpjenpwdUlveFdWZnQ0NUFkbW9WeldxWjhWZ05LT1B1Z1ZURzVETUJiY1RsYkxNclVweklnQVlpaFphcmo?oc=5","date":"2024-12-20","type":"pipeline","source":"drugdiscoverytrends.com","summary":"100 cell and gene therapy leaders to watch in 2025 - drugdiscoverytrends.com","headline":"100 cell and gene therapy leaders to watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"PR Newswire","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxONGl0M2pkNFg2SFZMdEFnS0Y1LVRkY3AtNXBpYUtLWkR6WXNOWUl3MlpEeHBZOV9jcUlnWVRscVpDWkJ0OHAxRlFYNGxiRU5mWGNaTS1GWEZJUjJoMG9ZQjlyUVBBYW10WUgzRUJ4eWtVcjk0ZHJzNnlqRGU0VVhzci1sQ0ZYRE16Qjk3N3dCZ1prWVNtUE5XYWROMTBieUxYR3JxUkk1Tlg4N3kzX2Z4LTY5RkhDZUpHX09TTmsyTGlqN0lQN0Iwck1pMXRXS2ctSkJDRE11VExQWm1zcjVTZXlEano4VEpHd1FCRTlrSG5Wbjd1Sk9Ma2k1dGtXQ3kwM1ktejBuc0hOaU5tX2l3TG9ydFhfYXQ4NnN1WGtocGlvcEp6bWZpOEJCc3FfTTVyY3c?oc=5","date":"2024-10-28","type":"trial","source":"PR Newswire","summary":"Treg Cell-based Therapies Clinical Trial Pipeline Appears Robust With 51+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Treg Cell-based Therapies Clinical Trial Pipeline Appears Robust With 51+ Key Pharma Companies Actively Working in the T","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}